---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-009500"
form_type: "8-K"
ticker: "FULC"
cik: "0001680581"
company_name: "Fulcrum Therapeutics, Inc."
filed_at: "2023-01-17T23:59:59+00:00"
generated_at: "2026-06-20T14:46:41.591580+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Fulcrum announces $100M stock offering and preliminary $202.9M cash position

## Summary
- Preliminary cash, cash equivalents, and marketable securities of ~$202.9M as of Dec 31, 2022.
- Commenced underwritten public offering of $100M common stock, with 30-day option for additional $15M.
- Terminated ATM equity distribution agreement with Piper Sandler effective Jan 17, 2023.
- Goldman Sachs, SVB Securities, Piper Sandler joint book-runners; H.C. Wainwright lead manager.

## SEC filing metadata
- accession: 0001193125-23-009500
- form_type: 8-K
- ticker: FULC
- cik: 0001680581
- company_name: Fulcrum Therapeutics, Inc.
- filed_at: 2023-01-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1680581/000119312523009500/0001193125-23-009500-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1680581/000119312523009500/d436290d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-009500
- JSON: https://secwatch.observer/filing/0001193125-23-009500.json
- Plain text: https://secwatch.observer/filing/0001193125-23-009500.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.